The Walter and Eliza Hall Institute of Medical Research is Australia's oldest medical research institute. In 2011, the institute is home to more than 650 researchers who are working to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C. Located in Parkville, Melbourne, it is closely associated with The University of Melbourne and The Royal Melbourne Hospital. The institute also has a campus at La Trobe University. The institute was founded in 1915 using funds from a trust established by Eliza Hall following the death of her husband Walter Russell Hall. The institute owes its origin to the inspiration of Harry Brookes Allen, who encouraged the use of a small portion of the charitable trust to found a medical research institute. The vision was for an institute that 'will be the birthplace of discoveries rendering signal service to mankind in the prevention and removal of disease and the mitigation of suffering.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A recent study by WEHI and ENDIA has found type 1 diabetes is associated with changes in the gut microbiome during pregnancy and could contribute to complications in both the mother and baby.
Oct 18, 2021
0
42
Scientists have discovered an important cause of stroke occurring in the womb or just after birth, paving the way for new treatments.
Sep 13, 2021
0
140
Melbourne researchers have led a global collaboration to develop a simplified blood test that increases the overall screening efficiency for type 1 diabetes (T1D).
Sep 06, 2021
0
13
WEHI researchers have made a discovery that could help more Australian women with ovarian cancer gain access to game-changing cancer treatments called PARP inhibitors.
Jul 29, 2021
0
578
Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically.
Jul 23, 2021
0
0
A genetic map of an aggressive childhood brain tumour called medulloblastoma has helped researchers identify a new generation anti-cancer drug that can be repurposed as an effective treatment for the disease.
Jul 07, 2021
0
6
WEHI researchers have documented the diversity of cells in the human breast, explaining the relationship between healthy breast cells and breast cancer cells.
May 14, 2021
0
8
A novel approach to immunotherapy design could pave the way for new treatments for people with an aggressive form of brain cancer called glioblastoma.
May 10, 2021
0
10
WEHI researchers have identified how natural human antibodies can block malaria parasites from entering red blood cells, potentially indicating how new protective therapies could be developed against this globally significant ...
May 03, 2021
0
83
WEHI researchers have discovered why some leukemia cells are resistant to new "SMAC-mimetic' anti-cancer agents, a finding which could improve the use of these drugs in the clinic.
Apr 15, 2021
0
1
